Meeting the challenges in screening. [Drug Discov Today. 2002] - PubMed

Supplemental Content

Genetic testing as part of the early hearing detection and intervention (EHDI) process. [Genet Med. 2004]
Genetic testing as part of the early hearing detection and intervention (EHDI) process.
Schimmenti LA, Martinez A, Fox M, Crandall B, Shapiro N, Telatar M, Sininger Y, Grody WW, Palmer CG. Genet Med. 2004 Nov-Dec; 6(6):521-5.
Review What's new in prenatal screening and diagnosis? [Prim Care. 2004]
Review What's new in prenatal screening and diagnosis?
Bubb JA, Matthews AL. Prim Care. 2004 Sep; 31(3):561-82, ix.
Genetic testing for deafness is here, but how do we do it? [Genet Med. 2004]
Genetic testing for deafness is here, but how do we do it?
Robin NH. Genet Med. 2004 Nov-Dec; 6(6):463-4.
Review Genetic testing to identify high-risk populations for chemoprevention studies. [Cancer Biomark. 2007]
Review Genetic testing to identify high-risk populations for chemoprevention studies.
Velasquez JL, Lipkin SM. Cancer Biomark. 2007; 3(3):163-8.
Implications of preclinical genetic diagnosis. [Med Sect Proc. 1990]
Implications of preclinical genetic diagnosis.
Hoar DI. Med Sect Proc. 1990; :147-55.

Meeting the challenges in screening.
Meeting the challenges in screening.
Drug Discov Today. 2002 Dec 1 ;7(23):1162-4.

PubMed
Calcification properties of saline-filled breast implants.
Calcification properties of saline-filled breast implants.
Plast Reconstr Surg. 2001 Feb ;107(2):356-63.

PubMed
Practical approaches to proteomic biomarkers within prostate cancer radiotherapy...
Practical approaches to proteomic biomarkers within prostate cancer radiotherapy trials.
Cancer Metastasis Rev. 2008 Sep ;27(3):375-85.

PubMed
MPH1, a yeast gene encoding a DEAH protein, plays a role in protection of the ge...
MPH1, a yeast gene encoding a DEAH protein, plays a role in protection of the genome from spontaneous and chemically induced damage.
Genetics. 2000 Jul ;155(3):1069-81.

PubMed
New ocular therapeutics: a view from the patenting perspective.
New ocular therapeutics: a view from the patenting perspective.
IDrugs. 2007 Jan ;10(1):37-41.

PubMed

Your browsing activity is empty.

Activity recording is turned off.